Clinical Trial Update: Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating clonidine hydrochloride topical gel 0.1% for pain associated with diabetic neuropathy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Neuropathy
• Painful Diabetic Neuropathy

Drugs mentioned

• Clonidine hydrochloride topical gel 0.1% (clonidine hydrochloride topical gel)

Snippet

Sponsor: BioDelivery Sciences International | Conditions: Painful Diabetic Neuropathy, Diabetic Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2017-08-24